Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01412983 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens
A NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT01412983: Completed NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
NCT01412983 is a NA study of Myopia that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 100 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01412983, a NA study of Myopia, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses developed by Bausch + Lomb.
Primary Outcome
The mean difference in high contrast logMAR, over all lens visual acuities (VAs) between lens groups.
Conditions Studied
Interventions
- DEVICE Bausch & Lomb Test lens
- DEVICE Ciba Vision soft contact lens
Study Locations (1)
New York
- Bausch & Lomb Incorporated - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-08 |
| Est. Completion | 2011-10 |
| Phase | NA |
What the finished NCT01412983 record still lists
NCT01412983 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Bausch & Lomb Test lens is the first listed.
NCT01412983 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01412983 about?
NCT01412983 is a clinical study titled "A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens". The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses developed by Bausch + Lomb.
What is the current status of trial NCT01412983?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2011-08. Estimated completion is 2011-10.
What conditions does trial NCT01412983 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT01412983?
The interventions under investigation include: Bausch & Lomb Test lens (DEVICE), Ciba Vision soft contact lens (DEVICE).
Who is sponsoring clinical trial NCT01412983?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01412983 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01412983's enrollment target sits among peer trials
100 40th of 90 higher than 51 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia